|


Stop by the ALZET booth during one
of these upcoming exhibits in 2008:
Scand-LAS
Tartu, Estonia
May 8-10
Exhibit: 4
The Endocrine
Society's 90th Annual Meeting (ENDO 2008)
San Francisco, CA
June 15-18
Exhibit: TBD
EACR
Lyon, France
July 5-8
Exhibit: TBD
FENS
Geneva, Switzerland
July 13-16
Exhibit: TBD
Complete
2008 schedule
|
 |
“Galantamine was administered via…osmotic pump… A minipump was used in order to better mimic the daily multiple dosing regimen given to patients with Alzheimer’s disease.” Wenk et al., European Journal of Pharmacology 2003;453:319-324. |
 |
|
|
 |
ALZET®
Osmotic Pumps are miniature, infusion pumps for the continuous
dosing of laboratory animals as small as mice and young rats.
These minipumps provide researchers with a convenient and reliable
method for controlled agent delivery in vivo.
|
ALZET®
Osmotic Pumps require no external connections or researcher intervention
during the entire delivery period. Their unique design helps researchers
save critical time by eliminating the need for frequent animal
handling and repetitive injection schedules. These dependable
drug delivery systems have proven invaluable in predictably sustaining
compounds at therapeutic levels, avoiding potentially toxic or
misleading side effects and ensuring accurate research results.
An assortment of sizes, flow rates and durations is available
to meet a variety of research needs. A single ALZET pump provides
up to 6 weeks of continuous infusion.
|
|
 |
 |
 |
| |
Download
the Neuroscience focus Newsletter

|
Neuroscience
Research ALZET pumps are used in
neuroscience research as an essential method to overcome the blood-brain
barrier and deliver neuroactive compounds to the CNS. ALZET pumps and Brain
Infusion Kits have been instrumental to the study of neurodegenerative
diseases, cognitive research, neuroprotection, spinal cord injury,
cerebral ischemia, and more.
Click here for more
information on the use of ALZET pumps in neuroscience.
|
|
|
 |
  |
 |
|
|